Latest News
Conference Coverage
Postmenopausal women who shed pounds see lower breast cancer risk
SAN ANTONIO – Compared with peers who had stable weight, women who lost at least 5% of their body weight had a lower risk of invasive breast...
From the Journals
Leflunomide use in pregnancy shows little impact on newborns
A population-based study of leflunomide use in pregnancy is the largest of its kind published to date.
Conference Coverage
Early intervention key to treating substance use disorders
In utero exposure to nicotine, alcohol, and cannabis is associated with risks to offspring and mothers.
Conference Coverage
High rate of arm morbidity in young breast cancer survivors
SAN ANTONIO – A significant rate of arm swelling and decreased range of motion was seen in young breast cancer patients 1 year after surgery.
Video
MACRA Monday: Depression screening
Screen a patient for depression and document a follow-up plan, if needed, and you could avoid a 4% penalty under MIPS.
Feature
Maternal mortality is set to be a top issue for 2018
Women’s health advocates are focused on reducing maternal mortality and preserving access to preventive health care under the Affordable Care Act...
Feature
Survey: Safety, rather than ethics, tops concerns about uterine transplantation
For absolute uterine infertility, most physicians see transplantation as an option.
Feature
Medicaid’s share of state budgets continues to grow
States provided $574 billion in benefits during fiscal 2017.
Feature
After 6 weeks, HealthCare.gov activity still ahead of last year
As the end of this year’s open enrollment nears, however, plan selections are only about half of last year’s total.
Conference Coverage
VIDEO: SABCS 2017 roundtable with Dr. Hope S. Rugo and Dr. William J. Gradishar
SAN ANTONIO – Dr. Hope S. Rugo and Dr. William J. Gradishar share their reflections on duration of therapy, ovarian suppression, immunotherapy,...
Conference Coverage
CDK4/6 inhibitors have similar efficacy in older breast cancer patients
SAN ANTONIO – Treatment with CDK4/6 inhibitors appears to have the same efficacy in older breast cancer patients, as compared with younger ones....